This company has been marked as potentially delisted and may not be actively trading. Acelyrin (SLRN) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock SLRN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Millennium Management LLC Sells 772,770 Shares of Acelyrin, Inc. (NASDAQ:SLRN)May 25, 2025 | marketbeat.com132,870 Shares in Acelyrin, Inc. (NASDAQ:SLRN) Acquired by Stonepine Capital Management LLCMay 20, 2025 | marketbeat.comDimensional Fund Advisors LP Buys New Shares in Acelyrin, Inc. (NASDAQ:SLRN)May 19, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Decreases Stake in Acelyrin, Inc. (NASDAQ:SLRN)May 18, 2025 | marketbeat.comACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated DiseasesMay 13, 2025 | globenewswire.comDAFNA Capital Management LLC Sells 514,905 Shares of Acelyrin, Inc. (NASDAQ:SLRN)May 10, 2025 | marketbeat.comAcelyrin (SLRN) to Release Quarterly Earnings on TuesdayMay 8, 2025 | marketbeat.comAlyeska Investment Group L.P. Buys Shares of 1,515,878 Acelyrin, Inc. (NASDAQ:SLRN)May 8, 2025 | marketbeat.comLeading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with AlumisMay 6, 2025 | globenewswire.comSusquehanna Fundamental Investments LLC Takes $746,000 Position in Acelyrin, Inc. (NASDAQ:SLRN)May 5, 2025 | marketbeat.comAlmitas Capital LLC Raises Stake in Acelyrin, Inc. (NASDAQ:SLRN)May 4, 2025 | marketbeat.comAcelyrin urges stockholders to vote for proposed merger with AlumisMay 2, 2025 | finance.yahoo.comACELYRIN Reiterates Benefits of Value-Maximizing Combination with AlumisMay 1, 2025 | globenewswire.comT. Rowe Price Investment Management Inc. Boosts Stock Position in Acelyrin, Inc. (NASDAQ:SLRN)April 29, 2025 | marketbeat.comBank of Montreal Can Cuts Stock Holdings in Acelyrin, Inc. (NASDAQ:SLRN)April 28, 2025 | marketbeat.comJPMorgan Chase & Co. Sells 232,534 Shares of Acelyrin, Inc. (NASDAQ:SLRN)April 27, 2025 | marketbeat.comAcelyrin, Inc. (NASDAQ:SLRN) Short Interest UpdateApril 21, 2025 | marketbeat.comAlumis and ACELYRIN Announce Amended Merger AgreementApril 21, 2025 | globenewswire.comACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRNApril 16, 2025 | businesswire.comWellington Management Group LLP Buys New Shares in Acelyrin, Inc. (NASDAQ:SLRN)April 16, 2025 | marketbeat.comExodusPoint Capital Management LP Takes $423,000 Position in Acelyrin, Inc. (NASDAQ:SLRN)April 15, 2025 | marketbeat.comADAR1 Capital Management LLC Acquires 391,467 Shares of Acelyrin, Inc. (NASDAQ:SLRN)April 9, 2025 | marketbeat.comAlumis Inc.; ACELYRIN, INC.: Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed MergerApril 5, 2025 | finanznachrichten.deAlumis Inc. and ACELYRIN, INC. File Joint Definitive Proxy Statement for Proposed MergerApril 5, 2025 | finanznachrichten.deSTOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating The Merger - SLRN, TURN, BHLB, MHLDMarch 30, 2025 | morningstar.comMInsider Selling: Acelyrin, Inc. (NASDAQ:SLRN) Insider Sells 3,913 Shares of StockMarch 20, 2025 | marketbeat.comInsider Selling: Acelyrin, Inc. (NASDAQ:SLRN) CEO Sells 17,986 Shares of StockMarch 20, 2025 | marketbeat.comAcelyrin (NASDAQ:SLRN) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPSMarch 20, 2025 | marketbeat.comInsider Selling: Acelyrin, Inc. (NASDAQ:SLRN) Insider Sells 3,913 Shares of StockMarch 20, 2025 | insidertrades.comAcelyrin (SLRN) Projected to Post Quarterly Earnings on ThursdayMarch 20, 2025 | marketbeat.comAcelyrin, Inc. (SLRN): One of the Best Short-Term Stocks to Buy Right NowMarch 18, 2025 | msn.comACELYRIN Adopts Limited-Duration Stockholder Rights PlanMarch 13, 2025 | globenewswire.comAcelyrin: Potential Buyout Led By Concentra BiosciencesMarch 12, 2025 | seekingalpha.comAcelyrin, Inc. (NASDAQ:SLRN) Holdings Decreased by General Atlantic L.P.March 11, 2025 | marketbeat.comIs Acelyrin, Inc. (SLRN) the Best Micro Cap Stock to Buy Now?March 7, 2025 | insidermonkey.comACELYRIN, INC.: ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed MergerMarch 4, 2025 | finanznachrichten.deAcelyrin says Concentra indication not expected to result in superior proposalMarch 4, 2025 | markets.businessinsider.comAcelyrin falls as Acelyrin reaffirms deal commitmentMarch 4, 2025 | msn.comAcelyrin, Alumis reaffirm strategic, financial rationale of proposed mergerMarch 4, 2025 | markets.businessinsider.comACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed MergerMarch 4, 2025 | globenewswire.comACELYRIN Determines Unsolicited Indication of Interest From Concentra Biosciences Not Reasonably Expected to Result in a Superior Proposal to Planned Alumis MergerMarch 4, 2025 | globenewswire.comAcelyrin, Inc. (NASDAQ:SLRN) Sees Large Decrease in Short InterestMarch 4, 2025 | marketbeat.comAcelyrin (NASDAQ:SLRN) Stock Price Up 1.2% - Should You Buy?February 27, 2025 | marketbeat.comAcelyrin Stock Jumps on Concentra Acquisition InterestFebruary 21, 2025 | marketwatch.comAcelyrin Stock Jumps on Concentra Acquisition InterestFebruary 21, 2025 | marketwatch.comAcelyrin confirms unsolicited indication of interest from Concentra BiosciencesFebruary 21, 2025 | markets.businessinsider.comAcelyrin jumps 11% on acquisition offer from Concentra BiosciencesFebruary 21, 2025 | msn.comACELYRIN Confirms Receipt of Unsolicited Indication of Interest from Concentra BiosciencesFebruary 20, 2025 | globenewswire.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Acelyrin, Inc. BuyoutFebruary 12, 2025 | markets.businessinsider.comSLRN stock touches 52-week low at $1.85 amid market challengesFebruary 11, 2025 | msn.com Get Acelyrin News Delivered to You Automatically Sign up to receive the latest news and ratings for SLRN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SLRN Media Mentions By Week SLRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLRN News Sentiment▼0.001.09▲Average Medical News Sentiment SLRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLRN Articles This Week▼03▲SLRN Articles Average Week Get the Latest News and Ratings for SLRN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Acelyrin and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies URGN News IMNM News QURE News SANA News AKBA News PHAT News AMLX News AVXL News TSHA News AVBP News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLRN) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acelyrin, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acelyrin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
